191) stoperative urine samples from 865 adults who underwent cardiac surgery at 2 sites i |
192) nsecutive elderly patients (>65 years) who underwent elective total hip arthropla |
193) d for analysing compliance among patients who underwent non-extraction orthodontic t |
194) rt a case of an HIV/HCV co-infected woman who underwent simultaneous liver and kidne |
195) Totally 2 934 patients who underwent skin and soft tissue dilatat |
196) hy and stereo EEG in a cohort of patients who underwent surgery for temporal lobe ep |
197) piratory syndrome coronavirus 2 infection who underwent telerehabilitation in-hospit |
198) solated from explanted livers of patients who underwent transplant for end-stage irr |
199) nd lactate in people living with HIV/AIDS who completed a combined physical training |
200) Data from 48 healthy volunteers who completed both the BP and IC were coll |
201) hort selection and data analysis Patients who completed clear aligner therapy (CAT) |
202) Per trial design, all patients who completed cycle 12 discontinued ibruti |
203) ts were compared across 4,274 individuals who completed eligibility screeners over a |
204) , with data analyzed from 124 respondents who completed fragments such as "John like |
205) years (mage = 20.64, SD = 4.34) who completed measures of IGD and ADHD, a |
206) male) attending a northeastern university who completed the Big Five Inventory (BFI) |
207) ments were taken from 72% of participants who completed the intervention. |
208) ent, and forty-eight age-matched controls who completed the same auditory-perceptual |
209) a cohort of "Trusted" online participants who completed the test using both headphon |
210) In general, patients who took Sacituzumab Govitecan experienced |
211) The study showed that patients who took Sacituzumab Govitecan lived longe |
212) Tumors shrank in more patients who took Sacituzumab Govitecan than in pat |
213) Among the participants who took crizotinib, the most common side |
214) More participants who took lorlatinib had cancer that shrank |
215) most common side effects in participants who took lorlatinib were increases in the |
216) ter 1 year of treatment, the participants who took lorlatinib were twice as likely t |
217) Participants who took osimertinib have stayed cancer-fr |
218) All who took part had already received 2 previ |
219) sets of the lower leg of 76 participants, who took part in eight different bed rest |
220) All those who took part had changes in a gene calle |
221) have implications for patients taking CBD who may be at risk for clinically importan |
222) and conduct framework and to guide others who may be considering similar collaborati |
223) entify adult survivors of sexual assault, who may be particularly underserved when a |
|